AAB
REGN icon

ABN AMRO Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

ABN AMRO Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$526K Sell
678
-4
-0.6% -$3.06K 0.01% 184
2025
Q4 		$524K Sell
682
-111
-14% -$75.4K ﹤0.01% 197
2025
Q3 		$444K Sell
793
-121
-13% -$68.4K ﹤0.01% 207
2025
Q2 		$483K Sell
914
-220,569
-100% -$123M 0.01% 144
2025
Q1 		$140M Buy
221,483
+1,614
+0.7% +$1.11M 1.94% 23
2024
Q4 		$155M Buy
219,869
+6,247
+3% +$5.24M 2.09% 21
2024
Q3 		$223M Buy
213,622
+8,359
+4% +$9.3M 3.05% 14
2024
Q2 		$218M Buy
205,263
+6,353
+3% +$6.16M 3.3% 10
2024
Q1 		$192M Buy
198,910
+182,099
+1,083% +$173M 2.86% 14
2023
Q4 		$14.8M Sell
16,811
-241
-1% -$198K 0.24% 52
2023
Q3 		$14M Buy
17,052
+16,164
+1,820% +$12.7M 0.25% 50
2023
Q2 		$637K Buy
+888
New +$685K 0.01% 117

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

ABN AMRO Bank's REGN Position: Q1 2026 in Review

ABN AMRO Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 0.59% in Q1 2026, selling an estimated $3.06K and leaving 678 shares worth $526K. The position accounts for 0.01% of the portfolio, ranked #184.

ABN AMRO Bank first reported a position in REGN in Q2 2023 and has held it in 12 quarters since. The position peaked at $223M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • ABN AMRO Bank held 678 shares of Regeneron Pharmaceuticals worth $526K as of Q1 2026.
  • ABN AMRO Bank sold 4 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $3.06K.
  • Regeneron Pharmaceuticals made up 0.01% of ABN AMRO Bank's portfolio in Q1 2026, its #184 holding.
  • ABN AMRO Bank first reported a position in Regeneron Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • ABN AMRO Bank's Regeneron Pharmaceuticals position peaked at $223M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.